RxSight (NASDAQ: RXST) net income
RxSight reported a net loss of $38.9m for fiscal 2025; in fiscal 2024 it reported a net loss of $27.5m. Earnings per share were −$0.95.
RxSight's best year of the last 6 was fiscal 2020. It reported a loss in 5 of those 6 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | −$38.9m | — | −29.0% | −$0.95 |
| 2024 | −$27.5m | — | −19.6% | −$0.71 |
| 2023 | −$48.6m | — | −54.6% | −$1.41 |
| 2022 | −$66.8m | — | −136.2% | −$2.41 |
| 2021 | −$48.7m | −276.6% | −215.5% | −$3.57 |
| 2020 | $27.6m | — | 187.9% | $0.91 |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
RxSight net income compared with its sector
By net income for its latest fiscal year, RxSight ranks 238th of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of RxSight, −29.0%.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 236th | Monte Rosa Therapeutics | −$38.6m | −31.2% |
| 237th | Lifecore Biomedical | −$38.7m | −30.0% |
| 238th | RxSight | −$38.9m | −29.0% |
| 239th | Spruce Biosciences | −$39.0m | — |
| 240th | TriSalus Life Sciences | −$39.2m | −86.9% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of RxSight
- How much did RxSight earn in fiscal 2025?
- RxSight reported a net loss of $38.9m for fiscal 2025. In fiscal 2024 it reported a net loss of $27.5m.
- What are the earnings per share of RxSight?
- They were −$0.95 in fiscal 2025, compared with −$0.71 in fiscal 2024.
- What was the most profitable year for RxSight?
- Of its last 6 fiscal years, fiscal 2020, with $27.6m.
- Where does RxSight rank in its sector by net income?
- It ranks 238th of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for RxSight come from?
- From the annual report (Form 10-K) that RxSight files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that RxSight files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020. More on RxSight: the RxSight page · annual accounts · revenue · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.